Omeros reported $20.86M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.64M 54K
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Adma Biologics ADMA:US $ 13.87M 631.53K
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Cytokinetics CYTK:US $ 26.2M 5M
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Gilead Sciences GILD:US $ 1.18B 173M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Insmed INSM:US $ 60.28M 3.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Knight Therapeutics Inc GUD:CN C$ 18.75M 118K
Macrogenics MGNX:US $ 17.16M 1.93M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Omeros OMER:US $ 20.86M 699K
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Pfizer PFE:US $ 2.73B 61M
Regulus Therapeutics RGLS:US $ 2.5M 16K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
United Therapeutics UTHR:US $ 109.1M 3.7M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Xoma XOMA:US $ 4.26M 328K